Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma. Brunsgaard EK, Bowles TL, Asare EA, Grossmann K, et al. Melanoma Res 2023 Apr 5. doi: 10.1097/CMR.0000000000000892.

Read + Share

Amedeo Smart

Independent Medical Education

Brunsgaard EK, Bowles TL, Asare EA, Grossmann K, et al. Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma. Melanoma Res 2023 Apr 5. doi: 10.1097/CMR.0000000000000892.
PMID: 37040662